YS Biopharma Announces Name Change to LakeShore Biopharma

Rhea-AI Summary

YS Biopharma announced a name change to LakeShore Biopharma, effective May 24, 2024. This rebranding aims to align with the company's global market positioning. The ticker symbol on Nasdaq will change from 'YS' to 'LSB' starting May 28, 2024. Shareholders' rights and the company's financial position remain unaffected. The CUSIP number will also stay the same.

Positive

• Name change aligns with global market positioning.
• No impact on shareholders' rights or financial position.
• Ticker symbol change signifies a fresh market presence starting May 28, 2024.
• CUSIP number remains unchanged, simplifying transitions for shareholders.

Negative

• Rebranding may lead to temporary market confusion during the transition.
• Cost implications of rebranding not disclosed, potential financial strain.
• Potential short-term volatility in stock performance due to ticker change.

GAITHERSBURG, Md., May 24, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced it is changing its legal name from "YS Biopharma Co., Ltd." to "LakeShore Biopharma Co., Ltd".

Dr. David Shao, Director, President, Co-Chief Executive Officer, and Chief Business Officer of the Company, commented, "We have decided to change our company name to LakeShore Biopharma to align with our global market positioning and international brand image. This change marks one of the first steps for us to expand our market reach, and we are eager to move forward and drive success under our new company name."

The name change and trading symbol change will not affect any rights of shareholders or the Company's operations and financial position. The Company's ordinary shares and warrants will continue to be listed on the Nasdaq. Effective with the opening of the trading day on May 28, 2024, the ticker symbol of the Company's ordinary shares and warrants will change from "YS" to "LSB" and from "YSBPW" to "LSBPW", respectively. There is no action required by the Company's current shareholders with respect to the company name or ticker symbol changes. The Company's CUSIP will not change in connection with the name change.

About LakeShore Biopharma (formerly known as YS Biopharma)

LakeShore Biopharma, previously known as YS Biopharma, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The Company operates in China, the United States, Singapore, and the Philippines, and is led by a management team that combines rich local expertise and global experience in the biopharmaceutical industry. For more information, please visit investor.ysbiopharma.com.

Investor Relations Contact

Alyssa Li
Director of Investor Relations
Email: ir@yishengbio.com

Robin Yang
Partner, ICR, LLC
Tel: +1 (212) 537-4035
Email: YSBiopharma.IR@icrinc.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ys-biopharma-announces-name-change-to-lakeshore-biopharma-302155079.html

SOURCE YS Biopharma Co., Ltd.

FAQ

What is the new name of YS Biopharma?

YS Biopharma is now called LakeShore Biopharma.

When does the ticker symbol change from 'YS' to 'LSB'?

The ticker symbol will change on May 28, 2024.

Will the name and ticker symbol change affect shareholders?

No, shareholders' rights and the company's financial position will not be affected.

Is there any action required by shareholders due to the name change?

No action is required by the company's current shareholders.

What is the new ticker symbol for YS Biopharma's warrants?

The new ticker symbol for the warrants is 'LSBPW'.

Will the CUSIP number change with the name change?

No, the CUSIP number will remain the same.